AddLife AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2025. For the third quarter, the company reported sales was SEK 2,429 million compared to SEK 2,344 million a year ago. Net income was SEK 81 million compared to SEK 24 million a year ago. Basic earnings per share from continuing operations was SEK 0.66 compared to SEK 0.19 a year ago. Diluted earnings per share from continuing operations was SEK 0.66 compared to SEK 0.19 a year ago.
For the nine months, sales was SEK 7,709 million compared to SEK 7,468 million a year ago. Net income was SEK 300 million compared to SEK 158 million a year ago. Basic earnings per share from continuing operations was SEK 2.47 compared to SEK 1.3 a year ago. Diluted earnings per share from continuing operations was SEK 2.47 compared to SEK 1.3 a year ago.
AddLife AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The Company operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The Company operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
